FDA – Page 2 – Policy & Medicine

FDA Issues Draft Guidance on Diversity Action Plans

OPDP Considers Potential Misleading Implications of Television Ads

Prominently Displaying Methodology of Studies Improves Physician Perception of Information

FDA Seeking Comments on Draft Guidance on Biosimilar Drugs and Reference Products

FDA Leaders Illuminate Regulatory Path Forward at Dermatology Meeting in San Diego

FDA Issues Final Rule, Confirming IVDs are Devices Under the FD&C Act

FDA Will Hold Listening Session on Future of Advisory Committees

Senators Urge FDA to Crack Down on Social Media Prescription Drug Promotion

FDA Issues Guidance Documents on Direct-to-Consumer Advertisements